2-Azabicyclo[2.2.1]heptan-6-ol hydrochloride
97%
- Product Code: 128367
CAS:
2007916-89-2
| Molecular Weight: | 149.62 g./mol | Molecular Formula: | C₆H₁₂ClNO |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD29918544 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of cholinesterase inhibitors and nootropic agents. Its rigid bicyclic structure makes it valuable in medicinal chemistry for designing compounds with high selectivity and potency. Commonly employed in the production of drugs targeting cognitive disorders, including Alzheimer’s disease. Also utilized in the preparation of enzyme inhibitors and receptor ligands due to its favorable stereochemistry and ability to mimic natural neurotransmitters.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿22,030.00 |
+
-
|
2-Azabicyclo[2.2.1]heptan-6-ol hydrochloride
Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of cholinesterase inhibitors and nootropic agents. Its rigid bicyclic structure makes it valuable in medicinal chemistry for designing compounds with high selectivity and potency. Commonly employed in the production of drugs targeting cognitive disorders, including Alzheimer’s disease. Also utilized in the preparation of enzyme inhibitors and receptor ligands due to its favorable stereochemistry and ability to mimic natural neurotransmitters.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :